Preparation and in vitro cytocompatibility of chitosan-siloxane hybrid hydrogels

Yuki Shirosaki, Masashi Hirai, Satoshi Hayakawa, Eiji Fujii, Maria A. Lopes, José D. Santos, Akiyoshi Osaka

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Injectable systems can be used in minimally invasive surgical applications. Although chitosan-glycerophosphate hydrogel systems are biodegradable and biocompatible, the long periods of time required for their effective gelation have severely limited their clinical application. The challenges currently facing researchers in this field are therefore focused on shortening the gelation time and biocompatibility of these materials to develop hydrogels suitable for clinical application. Chitosan and γ-glycidoxypropyltrimethoxysilane (GPTMS) hybrids have recently demonstrated good cytocompatibility with respect to human osteoblastic cells (MG63) and human bone marrow cells. Although these precursor sols could form gels under physiological conditions, they required neutralization with a sodium hydroxide solution. In this study, the chitosan-GPTMS hybrid systems were neutralized with glycerophosphate to prepare injectable hydrogels. The results revealed that the gelation time of the hydrogels could be controlled by the amount of GPTMS in the precursor sols. The in vitro cytocompatibility of the hydrogels were evaluated in terms of the proliferation of MG63 cells cultured either directly onto the hydrogels or indirectly onto the cell culture plate under a hydrogel insert. In the former case, the cells showed good attachment and proliferated for up to 7 days. Similar results were observed in the in direct culture. These results suggest that this new chitosan-GPTMS hydrogel could potentially be used as an injectable biomaterial in clinical applications.

Original languageEnglish
Pages (from-to)289-299
Number of pages11
JournalJournal of Biomedical Materials Research - Part A
Volume103
Issue number1
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Siloxanes
Hydrogels
Chitosan
Hydrogel
Gelation
Glycerophosphates
Polymethyl Methacrylate
Injections
Sols
Sodium Hydroxide
Biocompatible Materials
Hybrid systems
Biocompatibility
Cell culture
Bone Marrow Cells
Cultured Cells
Bone
Cell Culture Techniques
Gels
Cells

Keywords

  • biodegradability
  • chitosan-siloxane hybrid
  • cytocompatibility
  • hydrogel
  • silicon species

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Ceramics and Composites
  • Metals and Alloys
  • Medicine(all)

Cite this

Preparation and in vitro cytocompatibility of chitosan-siloxane hybrid hydrogels. / Shirosaki, Yuki; Hirai, Masashi; Hayakawa, Satoshi; Fujii, Eiji; Lopes, Maria A.; Santos, José D.; Osaka, Akiyoshi.

In: Journal of Biomedical Materials Research - Part A, Vol. 103, No. 1, 01.01.2015, p. 289-299.

Research output: Contribution to journalArticle

Shirosaki, Yuki ; Hirai, Masashi ; Hayakawa, Satoshi ; Fujii, Eiji ; Lopes, Maria A. ; Santos, José D. ; Osaka, Akiyoshi. / Preparation and in vitro cytocompatibility of chitosan-siloxane hybrid hydrogels. In: Journal of Biomedical Materials Research - Part A. 2015 ; Vol. 103, No. 1. pp. 289-299.
@article{4b6d831a73b94efbaf2efd39ba14b79b,
title = "Preparation and in vitro cytocompatibility of chitosan-siloxane hybrid hydrogels",
abstract = "Injectable systems can be used in minimally invasive surgical applications. Although chitosan-glycerophosphate hydrogel systems are biodegradable and biocompatible, the long periods of time required for their effective gelation have severely limited their clinical application. The challenges currently facing researchers in this field are therefore focused on shortening the gelation time and biocompatibility of these materials to develop hydrogels suitable for clinical application. Chitosan and γ-glycidoxypropyltrimethoxysilane (GPTMS) hybrids have recently demonstrated good cytocompatibility with respect to human osteoblastic cells (MG63) and human bone marrow cells. Although these precursor sols could form gels under physiological conditions, they required neutralization with a sodium hydroxide solution. In this study, the chitosan-GPTMS hybrid systems were neutralized with glycerophosphate to prepare injectable hydrogels. The results revealed that the gelation time of the hydrogels could be controlled by the amount of GPTMS in the precursor sols. The in vitro cytocompatibility of the hydrogels were evaluated in terms of the proliferation of MG63 cells cultured either directly onto the hydrogels or indirectly onto the cell culture plate under a hydrogel insert. In the former case, the cells showed good attachment and proliferated for up to 7 days. Similar results were observed in the in direct culture. These results suggest that this new chitosan-GPTMS hydrogel could potentially be used as an injectable biomaterial in clinical applications.",
keywords = "biodegradability, chitosan-siloxane hybrid, cytocompatibility, hydrogel, silicon species",
author = "Yuki Shirosaki and Masashi Hirai and Satoshi Hayakawa and Eiji Fujii and Lopes, {Maria A.} and Santos, {Jos{\'e} D.} and Akiyoshi Osaka",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/jbm.a.35171",
language = "English",
volume = "103",
pages = "289--299",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "1549-3296",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Preparation and in vitro cytocompatibility of chitosan-siloxane hybrid hydrogels

AU - Shirosaki, Yuki

AU - Hirai, Masashi

AU - Hayakawa, Satoshi

AU - Fujii, Eiji

AU - Lopes, Maria A.

AU - Santos, José D.

AU - Osaka, Akiyoshi

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Injectable systems can be used in minimally invasive surgical applications. Although chitosan-glycerophosphate hydrogel systems are biodegradable and biocompatible, the long periods of time required for their effective gelation have severely limited their clinical application. The challenges currently facing researchers in this field are therefore focused on shortening the gelation time and biocompatibility of these materials to develop hydrogels suitable for clinical application. Chitosan and γ-glycidoxypropyltrimethoxysilane (GPTMS) hybrids have recently demonstrated good cytocompatibility with respect to human osteoblastic cells (MG63) and human bone marrow cells. Although these precursor sols could form gels under physiological conditions, they required neutralization with a sodium hydroxide solution. In this study, the chitosan-GPTMS hybrid systems were neutralized with glycerophosphate to prepare injectable hydrogels. The results revealed that the gelation time of the hydrogels could be controlled by the amount of GPTMS in the precursor sols. The in vitro cytocompatibility of the hydrogels were evaluated in terms of the proliferation of MG63 cells cultured either directly onto the hydrogels or indirectly onto the cell culture plate under a hydrogel insert. In the former case, the cells showed good attachment and proliferated for up to 7 days. Similar results were observed in the in direct culture. These results suggest that this new chitosan-GPTMS hydrogel could potentially be used as an injectable biomaterial in clinical applications.

AB - Injectable systems can be used in minimally invasive surgical applications. Although chitosan-glycerophosphate hydrogel systems are biodegradable and biocompatible, the long periods of time required for their effective gelation have severely limited their clinical application. The challenges currently facing researchers in this field are therefore focused on shortening the gelation time and biocompatibility of these materials to develop hydrogels suitable for clinical application. Chitosan and γ-glycidoxypropyltrimethoxysilane (GPTMS) hybrids have recently demonstrated good cytocompatibility with respect to human osteoblastic cells (MG63) and human bone marrow cells. Although these precursor sols could form gels under physiological conditions, they required neutralization with a sodium hydroxide solution. In this study, the chitosan-GPTMS hybrid systems were neutralized with glycerophosphate to prepare injectable hydrogels. The results revealed that the gelation time of the hydrogels could be controlled by the amount of GPTMS in the precursor sols. The in vitro cytocompatibility of the hydrogels were evaluated in terms of the proliferation of MG63 cells cultured either directly onto the hydrogels or indirectly onto the cell culture plate under a hydrogel insert. In the former case, the cells showed good attachment and proliferated for up to 7 days. Similar results were observed in the in direct culture. These results suggest that this new chitosan-GPTMS hydrogel could potentially be used as an injectable biomaterial in clinical applications.

KW - biodegradability

KW - chitosan-siloxane hybrid

KW - cytocompatibility

KW - hydrogel

KW - silicon species

UR - http://www.scopus.com/inward/record.url?scp=84912534963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912534963&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.35171

DO - 10.1002/jbm.a.35171

M3 - Article

C2 - 24677593

AN - SCOPUS:84912534963

VL - 103

SP - 289

EP - 299

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 1549-3296

IS - 1

ER -